Showing results (121-130 of 178) with videos related to
Sort By:
Pageof 18
Cell|April 26, 2025
RNA polymerase II partitioning is a shared feature of diverse oncofusion condensatesHeankel Lyons, Prashant Pradhan, Gopinath Prakasam, et al.Cancer Discovery|May 6, 2017
Modeling Renal Cell Carcinoma in Mice: Bap1 and Pbrm1 Inactivation Drive Tumor GradeYi-Feng Gu, Shannon Cohn, Alana Christie, et al.Nature Chemical Biology|September 13, 2011
Chemical inhibition of RNA viruses reveals REDD1 as a host defense factorMiguel A Mata, Neal Satterly, Gijs A Versteeg, et al.European Urology Oncology|August 19, 2022
Stereotactic Ablative Radiation for Systemic Therapy-naïve Oligometastatic Kidney CancerRaquibul Hannan, Michael Christensen, Alana Christie, et al.European Urology|March 10, 2023
Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal CancerRaquibul Hannan, Mark F McLaughlin, Laurentiu M Pop, et al.Advances in Radiation Oncology|October 14, 2021
Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell CarcinomaJonathan E Schoenhals, Osama Mohamad, Alana Christie, et al.Urologic Oncology|February 11, 2022
Stereotactic ablative radiation therapy for renal cell carcinoma with inferior vena cava tumor thrombusYuval Freifeld, Ivan Pedrosa, Mark Mclaughlin, et al.Journal of the National Cancer Institute|March 11, 2025
Determinants of late metastases in renal cell carcinomaPayal Kapur, Hua Zhong, Alana Christie, et al.Clinical Genitourinary Cancer|September 1, 2024
Pathological Response and Outcomes in Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Immunotherapy-Based Therapies and Undergoing Deferred Cytoreductive Nephrectomy (CN)Damla Gunenc, Wadih Issa, Thomas Gerald, et al.Molecular Cell|June 28, 2022
An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinomaJin Zhou, Jeremy M Simon, Chengheng Liao, et al.Pageof 18